Abstract
The small fraction of glutathione in mitochondria in nonneural tissues is an important contributor to cell survival under some conditions. However, there has been only limited characterization of the properties and function of mitochondrial glutathione in cells from the brain. In astrocytes in culture, highly selective depletion of this glutathione pool does not affect cell viability, at least in the first 24 h, but does greatly increase susceptibility to exposure to nitric oxide or peroxynitrite. In vivo, a selective partial loss of glutathione develops during focal cerebral ischemia and persists during reperfusion. The timing and distribution of glutathione loss shows an apparent association with the likelihood that tissue infarction will subsequently develop. Furthermore, infarct volume is greatly decreased by intracerebroventricular infusion of glutathione monoethylester, a compound that can increase mitochondrial glutathione. Together these recent findings indicate that alterations in mitochondrial glutathione are likely to contribute to the severity of tissue damage in stroke and possibly other neurological disorders. Thus, this antioxidant pool provides a potentially useful target for therapeutic intervention.
Similar content being viewed by others
REFERENCES
Anderson, M. F., Nilsson, M., Eriksson, P. S., and Sims, N. R. (2004a). Neurosci. Lett. 354, 163–165.
Anderson, M. F., Nilsson, M., and Sims, N. R. (2004b). Neurochem. Int. 44, 153–159.
Anderson, M. F., and Sims, N. R. (1999). J. Neurochem. 73, 1189–1199.
Anderson, M. F., and Sims, N. R. (2002). J. Neurochem. 81, 541–549.
Chen, Z., and Lash, L. H. (1998). J. Pharmacol. Exp. Ther. 285, 608–618.
Colell, A., Coll, O., Garcia-Ruiz, C., Paris, R., Tiribelli, C., Kaplowitz, N., and Fernandez-Checa, J. C. (2001). Hepatology 34, 964–971.
Colell, A., Garcia-Ruiz, C., Miranda, M., Ardite, E., Mari, M., Morales, A., Corrales, F., Kaplowitz, N., and Fernandez-Checa, J. C. (1998). Gastroenterology 115, 1541–1551.
Coll, O., Colell, A., Garcia-Ruiz, C., Kaplowitz, N., and Fernandez-Checa, J. C. (2003). Hepatology 38, 692–702.
Dhanboora, L. M., and Babson, J. R. (1992). Arch. Biochem. Biophys. 293, 130–139.
Dringen, R. (2000). Prog. Neurobiol. 62, 649–671.
Eliasson, M. J., Huang Z., Ferrante, R. J., Sasamata, M., Molliver, M. E., Snyder, S. H., and Moskowitz, M. A. (1999). J. Neurosci. 19, 5910–5918.
Fernandez-Checa, J. C., Garcia-Ruiz, C., Ookhtens, M., and Kaplowitz, N. (1991). J. Clin. Invest. 87, 397–405.
Folbergrova, J., Memezawa, H., Smith, M.-L., and Siesjo, B. K. (1992). J. Cereb. Blood Flow Metab. 12,25–33.
Folbergrova, J., Zhao, Q., Katsura, K.-I., and Siesjo, B. K. (1995). Proc. Natl. Acad. Sci. 92, 5057–5061.
Grattagliano, I., Vendemiale, G., and Lauterburg, B. H. (1999). J. Surg. Res. 86,2–8.
Griffith, O. W., and Meister A. (1985). Proc. Natl. Acad. Sci. 82, 4668–4672
Huang, J., and Philbert, M. A. (1996). Brain Res. 711, 184–192.
Kowaltowski, A. J., Castilho, R. F., and Vercesi, A. E. (2001). FEBS Letts. 495,12–15.
Kuroda, S., Katsura, K., Hillered, L., Bates, T. E., and Siesjo, B. K. (1996). Neurobiol. Dis. 3, 149–157.
Lash, L. H., Putt, D. A., and Matherly, L. H. (2002). J. Pharmacol. Exp. Ther. 303, 476–486.
Lash, L. H., Visarius, T. M., Sall, J. M., Qian, W., and Tokarz, J. J. (1998). J. Pharmacol. Exp. Ther. 303, 476–486.
Lipton, P. (1999). Physiol. Rev. 79, 1431–1568.
Liu, D., Lu, C. B., Wan, R. Q., Auyeng, W. W., and Mattson, M. P. (2002). J. Cereb. Blood Flow Metab. 22, 431–443.
Martensson, J., Jain, A., Frayer, W., and Meister, A. (1989). Proc. Natl. Acad. Sci. 90, 317–321.
Martensson, J., Lai, J., and Meister, A. (1990). Proc. Natl. Acad. Sci. 87, 7185–7189.
Matsumoto, S., Friberg, H., Ferrand-Drake, M., and Wieloch, T. (1999). J. Cereb. Blood Flow Metab. 19, 736–741.
Meister, A. (1995). Biochim. Biophys. Acta. 1271,35–42.
Meredith, M. J., and Reed, D. J. (1982). J. Biol. Chem. 257, 3747–3753.
Meredith, M. J., and Reed, D. J. (1983). Biochem. Pharmacol. 32, 1383–1388.
Muyderman, H., Nilsson, M., and Sims, N. R. (2004). Proc. Aust. Neu-rosci. Soc. 15, 34.
Muyderman, H., Nilsson, M., and Sims, N. R. (Accepted for publication). J. Neurosci.
Nakai, A., Kuroda, S., Kristian, A., and Siesjo, B. K. (1997). Neurobiol. Dis. 4, 288–300.
Radi, R., Cassina, A., and Hodara, R. (2002). Biol. Chem. 383, 401–409.
Raza, H., Robin, M. A., Fang, J. K., and Avadhani, N. G. (2002). Biochem. J. 366,45–55.
Rizzardini, M., Lupi, S., Bernasconi, A., Mangolini, A., and Cantoni, L. (2003). J. Neurol. Sci. 207,51–58.
Shan, X., Jones, D. P., Hashmi, M., and Anders, M. W. (1993). Chem. Res. Toxicol. 6,75–81.
Shimuzu, K., Lacza, Z., Rajapakse, N., Horiguchi, T., Snipes, J., and Busija, D. W. (2002). Am. J. Physiol. 283, H1005–H1011.
Sims, N. R., and Anderson, M. F. (2002). Neurochem. Int. 40, 511–526.
Wallin, C., Puka-Sundvall, M., Hagberg, H., Weber, S. G., and Sandberg, M. (2000). Dev. Brain Res. 125,51–60.
Wullner, U., Seyfried, J., Groscurth, P., Beinroth, S., Winter, S., Gleichmann, M., Heneka, M., Loschmann, P., Schulz, J. B., Weller, M., and Klockgether, T. (1999). Brain Res. 826,53–62.
Yoshimoto, T., and Siesjö, B. K. (1999). Brain Res. 839, 283–291.
Zhao, P., Kalhorn, T. F., and Slattery, J. T. (2002). Hepatology 36, 326–335.
Zheng, Z., Leem, J. E., and Yenari, M. A. (2003). Curr. Mol. Med. 3, 361–372.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sims, N.R., Nilsson, M. & Muyderman, H. Mitochondrial Glutathione: A Modulator of Brain Cell Death. J Bioenerg Biomembr 36, 329–333 (2004). https://doi.org/10.1023/B:JOBB.0000041763.63958.e7
Issue Date:
DOI: https://doi.org/10.1023/B:JOBB.0000041763.63958.e7